Kent MenB outbreak: 20 confirmed cases, 2 deaths
Parents across the North spent the weekend checking in on students after health officials confirmed 20 cases of invasive meningococcal disease linked to Kent as of 12:30pm on Friday 21 March, with a further nine notifications under investigation and two deaths. UKHSA says the overall risk to the wider public remains low. (gov.uk)
For families whose young people have headed back up north from Canterbury, the practical point is clear: eligible University of Kent students can now access both preventative antibiotics and the MenB vaccine via their local GP practice anywhere in England, with Scottish returnees advised to contact their local Health Protection Team first. (gov.uk)
UKHSA’s Saturday update noted that some cases initially counted as confirmed have been reclassified following further laboratory and clinical investigation, which is why the confirmed tally has dipped from earlier figures. More downgrades are possible as tests complete over the coming days. (gov.uk)
The vaccination offer has also been widened. Anyone offered antibiotics as part of this response is now eligible for the MenB jab, and the exposure window for Club Chemistry has been extended to 5–15 March after a suspected revisit before the venue’s voluntary closure. To ease pressure on pharmacies, 20,000 doses are being released from NHS supply into the private market. (gov.uk)
If you’re asking whether the jab will do the job, UKHSA’s lab work indicates the Bexsero vaccine being offered should protect against the circulating MenB strain (sequence type 485 within clonal complex ST‑41/44). Even so, antibiotics remain the most important immediate step to curb spread in this outbreak. (gov.uk)
Delivery on the ground has ramped up. By 5pm on Friday 20 March, partners in Kent and Medway had administered 4,500 vaccinations and more than 10,500 antibiotic courses; a day earlier the totals stood at 2,360 jabs and over 9,000 antibiotic doses. (gov.uk)
Case finding spans education settings. UKHSA reports confirmed cases in students at four schools in Kent and one student at a London higher education institution linked directly to the outbreak, with contact tracing and targeted offers of antibiotics and vaccine continuing. (gov.uk)
Confirmatory testing for meningococcal disease is carried out by the Meningococcal Reference Unit in Manchester - a reminder that laboratories in the North are central to the national response. (gov.uk)
Access in Kent remains straightforward today, Monday 23 March: Kent and Medway ICS says clinics are running 9am–5pm at the University of Kent Sports Centre and sites in Ashford, Canterbury and Faversham. If you’re eligible but already home in the North, your GP can arrange antibiotics and the MenB vaccine. (kmhealthandcare.uk)
‘We remain vigilant for new cases,’ said UKHSA infectious diseases consultant Dr Sherine Thomas, thanking students and partners for turning out in large numbers. Her advice is plain: know the symptoms and act fast, even though the wider risk is low. (gov.uk)
Symptoms can escalate quickly. Watch for a blotchy rash that doesn’t fade under a glass test, sudden high fever, severe headache, stiff neck, vomiting or diarrhoea, joint and muscle pain, sensitivity to light, very cold hands and feet, seizures, confusion or extreme sleepiness - and seek urgent help if they appear. (gov.uk)
Case numbers are being updated daily by UKHSA, and Kent & Medway ICS is keeping clinic details current. The Northern Ledger will continue to track the situation for northern families with ties to Kent and students heading back up for Easter. (ukhsa.blog.gov.uk)